Business Description
Lionco Pharmaceutical Group Co Ltd
ISIN : CNE1000022R8
Share Class Description:
SHSE:603669: Class ACompare
Compare
Traded in other countries / regions
603669.China IPO Date
2015-05-28Description
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.27 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -3.31 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.72 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -40.8 | |||||
3-Year Book Growth Rate | -14.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.96 | |||||
9-Day RSI | 50.03 | |||||
14-Day RSI | 49.39 | |||||
6-1 Month Momentum % | -15.26 | |||||
12-1 Month Momentum % | 5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.72 | |||||
Quick Ratio | 6.19 | |||||
Cash Ratio | 5.4 | |||||
Days Inventory | 196.92 | |||||
Days Sales Outstanding | 130.02 | |||||
Days Payable | 258.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 0.58 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.9 | |||||
Operating Margin % | -51.47 | |||||
Net Margin % | -72.13 | |||||
FCF Margin % | -27.23 | |||||
ROE % | -14.3 | |||||
ROA % | -8.39 | |||||
ROIC % | -11.08 | |||||
ROC (Joel Greenblatt) % | -26.29 | |||||
ROCE % | -9.87 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 32.98 | |||||
PS Ratio | 17.55 | |||||
PB Ratio | 3.8 | |||||
Price-to-Tangible-Book | 4.3 | |||||
EV-to-EBIT | -22.78 | |||||
EV-to-EBITDA | -22.78 | |||||
EV-to-Revenue | 16.28 | |||||
EV-to-FCF | -59.79 | |||||
Price-to-Projected-FCF | 3.85 | |||||
Price-to-Net-Current-Asset-Value | 19.24 | |||||
Price-to-Net-Cash | 120.25 | |||||
Earnings Yield (Greenblatt) % | -4.39 | |||||
FCF Yield % | -1.61 | |||||
Forward Rate of Return (Yacktman) % | -15.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lionco Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 200.39 | ||
EPS (TTM) (Â¥) | -0.2 | ||
Beta | 1.07 | ||
Volatility % | 36.74 | ||
14-Day RSI | 49.39 | ||
14-Day ATR (Â¥) | 0.202089 | ||
20-Day SMA (Â¥) | 4.8945 | ||
12-1 Month Momentum % | 5 | ||
52-Week Range (Â¥) | 2.94 - 6.07 | ||
Shares Outstanding (Mil) | 721.24 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lionco Pharmaceutical Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lionco Pharmaceutical Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Lionco Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Lionco Pharmaceutical Group Co Ltd(SHSE:603669)'s stock price today?
The current price of SHSE:603669 is ¥4.81. The 52 week high of SHSE:603669 is ¥6.07 and 52 week low is ¥2.94.
When is next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669)?
The next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is .
Does Lionco Pharmaceutical Group Co Ltd(SHSE:603669) pay dividends? If so, how much?
Lionco Pharmaceutical Group Co Ltd(SHSE:603669) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |